Combined treatment
Chemotherapy combined with targeted therapy
Targeted therapies act on specific features of cancer cells, such as particular proteins or genetic changes, found through tests on the tumour. For some cancers, including certain breast, bowel, stomach and lung cancers and some lymphomas, a targeted treatment is given alongside chemotherapy to improve its effect. The combination depends on test results. Targeted treatments have their own side effects, which your team monitors alongside those of chemotherapy.
On this page
- Why is chemotherapy combined with targeted therapy?
- Main groups of targeted medicines used with chemotherapy
- Where chemotherapy and targeted therapy are often combined
- What this page cannot tell you
- Four beliefs about targeted therapy with chemotherapy
- Common questions about chemotherapy with targeted therapy
The short answer
Why is chemotherapy combined with targeted therapy?
Chemotherapy and targeted therapy are combined because they work in different ways and can complement each other. Chemotherapy damages cells that divide quickly, including cancer cells. Targeted therapy acts on a specific feature of the cancer, such as a growth signal protein on the cell surface, a faulty internal switch, or the blood vessels a tumour needs to grow. When a cancer has one of these features, adding a targeted medicine to chemotherapy can make treatment more focused on the cancer. The combination is only offered when tests on the tumour tissue show the target is present, or when research supports it for that cancer type. Your team explains why it is suggested for you.
How it is given depends on the type of targeted medicine. The main groups are antibodies given by drip, often on the same day as chemotherapy; antibodies joined directly to a chemotherapy medicine, which carry it to the cancer cell; tablets that block signals inside the cell, sometimes taken alongside or after chemotherapy; and medicines that block the growth of new blood vessels feeding a tumour. Some antibodies can also be given as an injection under the skin. In many plans, the targeted medicine continues on its own after chemotherapy finishes. Your team sets the pattern, and you should never start, stop or change any of these medicines yourself. Ask for the pattern in writing, including any tablets taken at home.
Combinations are used in several cancers. Examples include some breast cancers with high levels of a particular growth signal protein, some bowel cancers, some stomach and oesophageal cancers, some lung cancers with specific gene changes, some head and neck cancers, some ovarian cancers and several types of lymphoma. Whether a combination suits you depends on tissue test results, the stage of treatment, your heart, kidney and liver health, and cost and access. Side effects reflect both treatments, with some particular to the targeted group, such as skin rash, raised blood pressure or effects on heart function. Our targeted therapy pages explain these medicine groups in more depth. Ask which tissue tests were done, and how the results shaped your plan.
Two different ways of acting
Chemotherapy is broad; targeted therapy aims at a specific feature.
Tissue tests guide the choice
The target usually needs to be present in your cancer.
Given by drip, injection or tablet
Often alongside chemotherapy, sometimes continuing after it.
Ask your team: which feature of my cancer does the targeted medicine act on, and how will it be given with chemotherapy?How is it given?
Main groups of targeted medicines used with chemotherapy
Antibodies
Lock onto a protein on cancer cells; usually given by drip with chemotherapy.
Antibody-drug conjugates
An antibody carries a chemotherapy medicine directly to the cancer cell.
Signal-blocking tablets
Block faulty switches inside cancer cells; taken by mouth.
Blood vessel blockers
Reduce the new blood vessels a tumour needs to grow.
Maintenance medicines
Some targeted medicines continue alone after chemotherapy ends.
Which cancers?
Where chemotherapy and targeted therapy are often combined
- Breast
- Some cancers with high levels of a growth signal protein.
- Bowel
- Some cancers, depending on gene tests on the tumour.
- Stomach and oesophagus
- Some cancers with specific protein features.
- Lung
- Some cancers with particular gene changes or features.
- Head and neck and ovarian
- Selected situations, as decided by the tumour board.
- Lymphoma
- Several types, using antibodies against a protein on lymphoma cells.
Not sure whether this applies to you?
Ask an oncologistA temperature or shivering · breathlessness, chest pain, a racing heartbeat or swollen ankles · a severe headache or very high blood pressure reading · bleeding that does not stop, or blood in stools or vomit · severe tummy pain · a widespread or blistering rash · wheezing, flushing or swelling of the face during or after a drip.
Being straight with you
What this page cannot tell you
It cannot tell you whether targeted therapy suits your cancer, or which medicine your team will choose. That depends on tissue tests and your health.
It also cannot predict how you will respond. Your team monitors response with examinations and scans.
Why tissue tests come first
Most targeted medicines only make sense when the cancer has the specific feature they act on. Laboratory tests on the tumour tissue look for particular proteins or gene changes. Some tests take longer than a basic report, so your team may start chemotherapy first and add the targeted medicine once results are back.
Heart checks
Some antibodies used with chemotherapy can affect how well the heart pumps, especially when combined with certain chemotherapy medicines. A heart scan is often done before starting and repeated during treatment. If heart function falls, your team may pause treatment. Report breathlessness, swollen ankles or a racing heartbeat promptly.
Skin effects
Medicines that block growth signals can cause an acne-like rash, dry skin, cracked fingertips or nail-fold soreness. These are common and often manageable with creams, gentle skin care and sun protection. Your team may prescribe preventive skin treatments. Do not use home remedies on the rash without asking first.
Blood pressure, bleeding and healing
Blood vessel blockers can raise blood pressure, increase bleeding risk and slow wound healing. Your blood pressure will be checked regularly. These medicines are usually paused around surgery, so tell your team about any planned procedure, including dental work, well ahead of time. Keep a home blood pressure record if advised.
Drip reactions
Some antibodies can cause reactions during or soon after the first drips, such as fever, chills, flushing or breathlessness. Nurses watch closely and may give preventive medicines and slow the drip. Reactions usually become less likely with later treatments. Tell the nurse straight away if you feel unwell during a drip.
Tablets at home
Signal-blocking tablets are taken at home, which gives you more responsibility. Follow the instructions exactly, keep a diary, and check with your team or pharmacist before taking any other medicine, supplement or herbal product, because interactions can be significant. Never stop or change tablets without advice.
When the targeted medicine continues alone
In many plans, the targeted medicine carries on after chemotherapy finishes. This phase usually brings fewer side effects than the combination, but regular reviews, blood tests and sometimes heart scans continue. Ask your team how long this phase may last and what checks it involves.
Before surgery
For some breast and other cancers, chemotherapy and targeted therapy are given before surgery to shrink the tumour, then continued afterwards. The surgical and medical teams coordinate timing carefully. Our pages on chemotherapy and surgery order explain how that sequence is decided. Ask when the targeted medicine will be restarted after the operation.
Resistance and changes of plan
Over time, some cancers stop responding to a targeted medicine. Repeat tissue or blood tests may look for new changes that guide the next treatment. A change of plan does not mean treatment has failed completely; there may be other options your team can explain.
Cost and access
Targeted medicines are often expensive, and they may continue for a long time. Insurance cover, government schemes and manufacturer access programmes vary, and lower-cost biosimilar versions exist for some antibodies. Ask for a written estimate for the whole plan before treatment begins, including the phase after chemotherapy ends.
Fertility and pregnancy
Some targeted medicines can harm an unborn baby, and effects may persist for a while after stopping. Use reliable contraception during treatment and for as long as your team advises afterwards. If you hope to have children in the future, raise fertility preservation before treatment starts.
Clinical trials
New targeted medicines and combinations are being studied constantly. A clinical trial may offer access to treatments not yet widely available. Ask your team whether any trial could suit your cancer, what it involves, and how it compares with standard treatment for you. Taking part is always voluntary.
What to do next
Ask which tissue tests were done, which feature the targeted medicine acts on, how it will be given with chemotherapy, what heart, skin or blood pressure checks you need, how long it may continue, and what it will cost.
Commonly believed
Four beliefs about targeted therapy with chemotherapy
It is only suitable when the cancer has the right target or research supports it.
They have their own effects, such as rash, heart or blood pressure changes.
The targeted medicine often continues on its own.
They need the same care, monitoring and interaction checks.
Questions we are asked
Common questions about chemotherapy with targeted therapy
Why combine?
They act in different ways, and when the cancer has a suitable target they can complement each other.
How is it given?
By drip, injection under the skin or tablets, often alongside chemotherapy and sometimes continuing after.
Which cancers?
Including some breast, bowel, stomach, lung, head and neck and ovarian cancers, and lymphomas.
Do I need special tests first?
Usually yes. Tissue tests check whether the target is present.
Are side effects worse?
They are different, adding effects such as rash, blood pressure or heart changes.
Will I need heart scans?
With some antibodies, yes, before and during treatment.
Can targeted therapy replace chemotherapy?
For some cancers it can; in others both are needed. Your team decides.
Is it expensive?
Often yes. Ask about insurance, schemes, biosimilars and access programmes.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Targeted Therapy to Treat Cancer
- Cancer.Net (ASCO) — How Cancer Is Treated
- Cancer Research UK — Chemotherapy
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Talk to us
Asking about targeted therapy?
Tell us what has been found so far and we will help you reach the right specialist. One helpline serves every CION centre.